Publication:
RANDOMIZED TRIAL OF ORAL MISOPROSTOL TREATMENT FOR CERVICAL RIPENING BEFORE TANDEM APPLICATION IN CERVIX CANCER

Simple item page
dc.contributor.authorÇEPNİ, Kımıa
dc.contributor.authorGul, Sule
dc.contributor.authorCepni, Ismail
dc.contributor.authorGuralp, Onur
dc.contributor.authorSal, Veysel
dc.contributor.authorMayadagli, Alpaslan
dc.contributor.institutionauthorMAYADAĞLI, ALPASLAN
dc.date.accessioned2021-04-15T20:59:20Z
dc.date.available2021-04-15T20:59:20Z
dc.date.issued2011-11-01T00:00:00Z
dc.description.abstractPurpose: To investigate the efficacy of oral misoprostol administered to facilitate tandem application to the cervix as a part of brachytherapy in patients with cervical cancer.
dc.identifier.citationÇEPNİ K., Gul S., Cepni I., Guralp O., Sal V., Mayadagli A., -RANDOMIZED TRIAL OF ORAL MISOPROSTOL TREATMENT FOR CERVICAL RIPENING BEFORE TANDEM APPLICATION IN CERVIX CANCER-, INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, cilt.81, sa.3, ss.778-781, 2011
dc.identifier.doi10.1016/j.ijrobp.2010.06.051
dc.identifier.scopus80053606999
dc.identifier.urihttp://hdl.handle.net/20.500.12645/28762
dc.identifier.wosWOS:000296115500025
dc.titleRANDOMIZED TRIAL OF ORAL MISOPROSTOL TREATMENT FOR CERVICAL RIPENING BEFORE TANDEM APPLICATION IN CERVIX CANCER
dc.typeArticle
dspace.entity.typePublication
local.avesis.id5dfafed4-73b1-47a1-a93c-71e3cd28038f
local.indexed.atWOS
local.indexed.atScopus
local.publication.goal03 - Sağlık ve Kaliteli Yaşam
local.publication.isinternational1
relation.isAuthorOfPublication3f87e3db-e55d-48a8-b15f-c4f4d75c7839
relation.isAuthorOfPublication.latestForDiscovery3f87e3db-e55d-48a8-b15f-c4f4d75c7839
relation.isGoalOfPublication9c198c48-b603-4e2f-8366-04edcfc1224c
relation.isGoalOfPublication.latestForDiscovery9c198c48-b603-4e2f-8366-04edcfc1224c

Files

Collections

Diğer Yayınlar